MemorialCare Health System
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, MemorialCare Health System sits in the top decile of US sponsors by registered trial count (#714 of 15,742 sponsors by registered trial count).
MemorialCare Health System: 21 sponsored US clinical trials, 4 recruiting.
MemorialCare Health System sponsors 21 registered US clinical trials on ClinicalTrials.gov, 4 of them currently recruiting, and 14 completed. 1 of these trials are in Phase 3-4 (later-stage) and 4 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Preeclampsia Postpartum, with 2 trials.
Top-decile sponsor footprint
MemorialCare Health System ranks in the top decile of sponsors by registered trial count (#714 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
14 of 16 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (87.5%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
21 total, page 1 of 1
Aspirin for Postpartum Patients With Preeclampsia
NCT05924971
Analgesia-First Sedation in Trauma Patients
NCT05751863
Immediate Postpartum Glucose Tolerance Testing
NCT04199676
SBRT Boost for Unfavorable Prostate Cancer'
NCT02016248
Preeclampsia Educational Program Study (PrEPS)
NCT06373367
Continuous Glucose Monitoring in Neonatal Hyperinsulinism
NCT06363929
Hypertension In Postpartum Preeclampsia Study
NCT03011567
Patient Satisfaction During Outpatient Versus Inpatient Foley Catheter Induction of Labor
NCT02975167
The Effects of Increased IV Hydration on Nulliparous Women Undergoing an Induction of Labor
NCT02989571
Does Venous pCO2 Increase by 20 mmHg or More During Apnea Challenge Test?
NCT02503813
Intrapartum Rapid GBS Testing in Patients Presenting With Threatened Preterm Labor
NCT02511444
Proteinuria During Acute Pyelonephritis In Pregnancy
NCT02536638
Comparison of Staples Versus Subcuticular Suture in Class III Obese Women Undergoing Cesarean Delivery
NCT02466776
Supplemental Oxygen Study
NCT02464917
Impact of Telerehabilitation Training on Pediatric Cystic Fibrosis Patients: An Exploratory Study
NCT02715921
Pilot Study on Pairing Sedation Strategies and Weaning
NCT02219659
Stool Transplant in Pediatric Patients With Recurring C. Difficile Infection
NCT01972334
Comparing Anti-XA Levels in Post-Cesarean Patients Undergoing Enoxaparin Thromboprophylaxis
NCT02070237
Increased Cefazolin During Cesarean Delivery in Obese Population
NCT02049944
Effects of Rate and/or Presence of Dextrose on the Labor Course of Nulliparas
NCT01904617
Outpatient Cervical Ripening With Orally Administered Misoprostol in Diabetics
NCT00514618
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 2 |
| Phase 2 | 2 |
| Phase 4 | 1 |
What is open in the MemorialCare Health System pipeline
4 recruiting of 21 indexed (19% open); 14 completed (67%).
Phase mix: 1 late (III/IV) vs 4 early (I/II) (early-phase heavy).
Top condition: Preeclampsia Postpartum (2 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
MemorialCare Health System: open-pipeline peers nationwide
Peers matched on 21 registered trials and 19% open enrollment, not the therapeutic-area sidebar.
MemorialCare Health System sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 21 trials (± recruiting share)
- AEterna Zentaris · 21 trials · 0% recruiting
- Amphastar Pharmaceuticals · 21 trials · 5% recruiting
- Apellis Pharmaceuticals · 21 trials · 10% recruiting
- Array Biopharma, now a wholly owned subsidiary of Pfizer · 21 trials · 0% recruiting
Sponsors near 19% open enrollment (± trial volume)
- University of North Texas Health Science Center · 19% recruiting · 21 trials
- University of Wisconsin, Milwaukee · 19% recruiting · 21 trials
- Verastem · 19% recruiting · 21 trials
- Jonsson Comprehensive Cancer Center · 19% recruiting · 321 trials
Related
What to do with this MemorialCare Health System page
21 registered trials is a research-attention snapshot, not an endorsement of MemorialCare Health System or any single study.
- 4 of MemorialCare Health System's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Preeclampsia Postpartum is the condition MemorialCare Health System studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Preeclampsia Postpartum trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
MemorialCare Health System pipeline card: 21 registered trials from official public datasets.Report a data error.